Catalent Aktie 23576319 / US1488061029
61.70
USD
0.25
USD
0.41%
03.12.2024
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Catalent Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2024 | Catalent Inc | 0.00 | 0.00 | USD |
| 2023 | Catalent Inc | 0.00 | 0.00 | USD |
| 2022 | Catalent Inc | 0.00 | 0.00 | USD |
| 2021 | Catalent Inc | 0.00 | 0.00 | USD |
| 2020 | Catalent Inc | 0.00 | 0.00 | USD |
| 2019 | Catalent Inc | 0.00 | 0.00 | USD |
| 2018 | Catalent Inc | 0.00 | 0.00 | USD |
| 2017 | Catalent Inc | 0.00 | 0.00 | USD |
| 2016 | Catalent Inc | 0.00 | 0.00 | USD |
| 2015 | Catalent Inc | 0.00 | 0.00 | USD |
Gewinn je Aktie- Catalent
| -5.8 24 | -1.4 23 | 2.8 22 | 3.1 21 | 1.1 20 | 0.9 19 | 0.6 18 |
Umsatz je Aktie- Catalent
| 24.2 24 | 23.6 23 | 27.1 22 | 23.5 21 | 20.3 20 | 17.3 19 | 18.5 18 |
KGV- Catalent
| 38.0 22 | 34.7 21 | 64.5 20 | 59.9 19 | 66.5 18 |
Catalent Inc: Die Aktie (in USD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | -5.76 | -1.42 | 2.84 | 3.11 | 1.14 | 0.90 | 0.63 |
| Gewinn je Aktie unverwässert | -5.76 | -1.41 | 2.86 | 3.15 | 1.15 | 0.92 | 0.64 |
| Gewinn je Aktie verwässert | -5.76 | -1.41 | 2.83 | 3.11 | 1.14 | 0.90 | 0.63 |
| Dividende pro Aktie | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gesamtdividendenausschüttung in Mio. | 0.00 | 0.00 | 4.00 | 22.00 | 36.20 | 0.00 | 0.00 |
Catalent Inc: Unternehmenskennzahlen (in USD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 24.20 | 23.55 | 27.12 | 23.52 | 20.31 | 17.25 | 18.49 |
| KGV (Jahresendkurs, EPS unverwässert) | - | - | 37.97 | 34.75 | 64.54 | 59.94 | 66.49 |
| KGV (Jahresendkurs, EPS verwässert) | - | - | 37.97 | 34.75 | 64.54 | 59.94 | 66.49 |
| KGV (Jahresendkurs) | - | - | 37.97 | 34.75 | 64.54 | 59.94 | 66.49 |
| Dividendenrendite Jahresende in % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Eigenkapitalquote in % | 36.95 | 42.79 | 45.64 | 46.91 | 45.08 | 37.00 | 23.98 |
| Fremdkapitalquote in % | 63.05 | 57.21 | 54.36 | 53.09 | 54.92 | 63.00 | 76.02 |
Catalent Inc: GuV (in Mio. USD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 4’381.00 | 4’263.00 | 4’828.00 | 3’998.00 | 3’094.30 | 2’518.00 | 2’463.40 |
| Umsatzveränderung in % | 2.77 | -11.70 | 20.76 | 29.21 | 22.89 | 2.22 | 18.70 |
| Bruttoergebnis vom Umsatz | 953.00 | 1’040.00 | 1’640.00 | 1’352.00 | 1’044.50 | 856.30 | 798.80 |
| Bruttoergebnisveränderung in % | -8.37 | -36.59 | 21.30 | 29.44 | 21.98 | 7.20 | 14.05 |
| Operatives Ergebnis | 145.00 | 243.00 | 796.00 | 673.00 | 408.50 | 312.80 | 301.20 |
| Veränderung Operatives Ergebnis in % | -40.33 | -69.47 | 18.28 | 64.75 | 30.59 | 3.85 | 15.40 |
| Ergebnis vor Steuern | -1’027.00 | -342.00 | 605.00 | 715.00 | 260.40 | 160.30 | 152.00 |
| Veränderung Ergebnis vor Steuern in % | -200.29 | - | -15.38 | 174.58 | 62.45 | 5.46 | 12.09 |
| Ergebnis nach Steuer | -1’043.00 | -256.00 | 503.00 | 529.00 | 173.00 | 132.00 | 83.60 |
| Veränderung Ergebnis nach Steuer in % | -307.42 | - | -4.91 | 205.78 | 31.06 | 57.89 | -23.86 |
Catalent Inc: Bilanz (in Mio. USD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Gesamtverbindlichkeiten | 6’149 | 6’166 | 5’712 | 4’838 | 4’271 | 3’896 | 3’444 |
| Langzeit Gesamtverbindlichk. pro Aktie | 28.28 | 25.76 | 25.88 | 21.35 | 20.75 | 22.13 | 21.49 |
| Eigenkapital | 3’604 | 4’611 | 4’795 | 4’274 | 3’505 | 2’288 | 1’087 |
| Veränderung Eigenkapital in % | -21.84 | -3.84 | 22.48 | 35.06 | 72.38 | 54.74 | 50.20 |
| Bilanzsumme | 9’753 | 10’777 | 10’507 | 9’112 | 7’777 | 6’184 | 4’531 |
| Veränderung Bilanzsumme in % | -9.50 | 2.57 | 15.31 | 17.17 | 25.75 | 36.48 | 31.17 |
Catalent Inc: Sonstige Angaben (in USD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | -5.76 | -1.41 | 2.86 | 3.15 | 1.15 | 0.92 | 0.64 |
| Veränderung Gewinn je Aktie (unverwässert) in % | -307.41 | -149.49 | -9.24 | 172.65 | 26.20 | 42.98 | -27.27 |
| Gewinn je Aktie (verwässert) | -5.76 | -1.41 | 2.83 | 3.11 | 1.14 | 0.90 | 0.63 |
| Veränderung Gewinn je Aktie (verwässert) in % | -307.41 | -150.05 | -9.19 | 173.97 | 25.59 | 43.56 | -27.59 |
| Anzahl Mitarbeiter | 16’900 | 17’800 | 19’000 | 17’300 | 13’900 | 12’300 | 10’700 |
| Veränderung Anzahl Mitarbeiter in % | -5.06 | -6.32 | 9.83 | 24.46 | 13.01 | 14.95 | -0.93 |
Catalent Inc Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Catalent Inc | Quartalszahlen | 11.02.2025 |
| Catalent Inc | Quartalszahlen | 13.05.2025 |
| Catalent Inc | Quartalszahlen | 02.09.2025 |
| Catalent Inc | Quartalszahlen | 11.11.2025 |
Catalent Inc vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q1 2025 Earnings Release | 05.11.2024 |
| Quartalszahlen | Q4 2024 Earnings Release | 29.08.2024 |
| Quartalszahlen | Q3 2024 Earnings Release | 08.05.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 09.02.2024 |
| Hauptversammlung | Annual General Meeting | 25.01.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 15.11.2023 |
| Quartalszahlen | Q4 2023 Earnings Release | 29.08.2023 |
| Quartalszahlen | Q3 2023 Earnings Release | 12.06.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 07.02.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 01.11.2022 |
| Hauptversammlung | Annual General Meeting | 27.10.2022 |
| Quartalszahlen | Q4 2022 Earnings Release | 29.08.2022 |
| Quartalszahlen | Q3 2022 Earnings Release | 03.05.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 01.02.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99.07 |
| The Vanguard Group, Inc. | 11.12 |
| Vanguard Group, Inc. (Subfiler) | 10.70 |
| Janus Henderson Investors US LLC | 7.30 |
| T. Rowe Price Investment Management, Inc. | 6.18 |
| Artisan Partners Holdings LP | 4.26 |
| State Street Corp. | 4.11 |
| Veritas Asset Management LLP | 3.56 |
| Capital Research & Management Co. (World Investors) | 3.53 |
| Capital Research & Management Co. (World Investors) | 3.53 |
| Corvex Management LP | 3.12 |
| Vanguard Total Stock Market ETF | 2.99 |
| BlackRock Fund Advisors | 2.96 |
| Vanguard 500 Index Fund | 2.64 |
| Norges Bank (13F) | 2.53 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 10’700 | 12’300 | 13’900 | 17’300 | 19’000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.23 | 0.20 | 0.22 | 0.23 | 0.25 |
Bilanz (in Mio. USD) - Aktiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1’240 | 1’396 | 2’293 | 2’918 | 2’916 |
| Summe Anlagevermögen | 3’291 | 4’788 | 5’484 | 6’194 | 7’591 |
| Summe Aktiva | 4’531 | 6’184 | 7’777 | 9’112 | 10’507 |
Bilanz (in Mio. USD) - Passiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 3’444 | 3’896 | 4’271 | 4’838 | 5’712 |
| Summe Eigenkapital | 1’087 | 2’288 | 3’505 | 4’274 | 4’795 |
| Summe Passiva | 4’531 | 6’184 | 7’777 | 9’112 | 10’507 |
Adresse
| 14 Schoolhouse Road, 08873 Somerset | |
| Telefon | +1 (732) 537-6200 |
| URL | http://www.catalent.com |
Management
|
Alessandro Maselli
President, Chief Executive Officer & Director |
|
Aristippos Gennadios
Group President-Pharma & Consumer Health |
|
Charles Lickfold
Chief Information Officer & Senior Vice President |
|
Donald Eugene Morel
Independent Director |
|
Frank A. D'Amelio
Independent Director |
|
Frédéric Cédrone
Vice President-Corporate Innovation |
|
Gregory T. Lucier
Independent Director |
|
J. Martin Carroll
Independent Director |
|
Jack Stahl
Lead Independent Director |
|
John J. Greisch
Executive Chairman |
|
Joseph A. Ferraro
Secretary, Chief Compliance Officer & Senior VP |
|
Julien Meissonnier
Chief Scientific Officer & Vice President |
|
Karen Murphy Santiago
Vice President |
|
Lim Chin Wei
Manager-Global Scientific Affairs |
|
Lisa Evoli
Chief Human Resources Officer & Senior VP |
|
Matti Masanovich
Chief Financial Officer & Senior Vice President |
|
Michael J. Barber
Independent Director |
|
Michael J. Grippo
SVP-Strategy & Corporate Development |
|
Michael J. Hatzfeld
Chief Accounting Officer & Vice President |
|
Michelle R. Ryan
Independent Director |
|
Paul Surdez
Vice President-Investor Relations |
|
Ricardo Pravda
Chief Transformation Officer |
|
Ricardo Zayas
Senior VP-North America Biologic Operations |
|
Ricky Hopson
Chief of Staff & Head-Bio Product Delivery |
|
Rolf Allan Classon
Independent Director |
|
Scott Gunther
Senior Vice President-Quality & Regulatory Affairs |
|
Stephanie Smith Okey
Independent Director |
|
Steven Barg
Independent Director |